James William

The global obsessive-compulsive disorder drugs market size is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032 driven by increasing prevalence of OCD across the globe.

Obsessive-Compulsive Disorder (OCD) is a chronic mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions) that individuals feel compelled to perform. OCD drugs are medications designed to help manage and alleviate the symptoms of this disorder, improving patients' quality of life. The primary class of medications used for treating OCD includes selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, and fluvoxamine, which help increase serotonin levels in the brain, thereby reducing the severity of symptoms. Additionally, tricyclic antidepressants like clomipramine are also prescribed. These medications are often used in conjunction with cognitive-behavioral therapy (CBT) to provide a comprehensive treatment approach.